ISSN:
1432-2072
Keywords:
Key words 5-HT cell firing
;
Tricyclic antidepressants (TCAs)
;
Serotonin and noradrenaline reuptake inhibitors (SNRIs)
;
Venlafaxine
;
Selective serotonin reuptake inhibitors (SSRIs)
;
5-HT1A receptors
;
α1 Adrenoceptors
;
Dorsal raphé nucleus
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Improved clinical antidepressant efficacy may result if the acute inhibition of 5-HT cell firing induced by antidepressants is prevented. Here we examined whether inhibition of 5-HT cell firing by non-selective 5-HT uptake inhibiting antidepressant drugs is reversed by a selective 5-HT1A receptor antagonist. In addition, we examined whether concomitant blockade of NA uptake offsets the inhibition of 5-HT cell firing resulting from 5-HT uptake blockade. Antidepressants which block 5-HT uptake (paroxetine, clomipramine, amitriptyline, venlafaxine), all caused dose-dependent and complete inhibition of 5-HT cell firing. Desipramine, a selective NA uptake blocker, caused a slight reduction in firing. The selective 5-HT1A receptor antagonist, WAY 100635, reversed the inhibition of 5-HT cell firing induced by clomipramine, amitriptyline, venlafaxine, and paroxetine, but not that induced by the α1 adrenoceptor antagonist, prazosin. Desipramine, at a dose which increased extracellular NA in the DRN, reversed the effect of prazosin but did not alter the ability of paroxetine to inhibit 5-HT cell firing. Our data indicate that antidepressant drugs with 5-HT uptake blocking properties inhibit 5-HT cell firing via activation of 5-HT1A autoreceptors, and do so irrespective of their effects on NA uptake. These data are discussed in relation to the application of 5-HT1A receptor antagonists to enhance the clinical efficacy of antidepressant drugs.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s002130050238
Permalink